Prices plus VAT plus shipping costs
Ready to ship today,
Delivery time appr. 5-8 days
- Order number: 7TM0218N
- Content: 100 µl
- Host: Rabbit
The non-phospho-Dopamine Receptor 5 Antibody is directed against the distal end of the carboxyl-terminal tail of human D5. It can be used to detect total D5 receptors in Western blots independent of phosphorylation. The non-phospho-D5 antibody can also be used to isolate and enrich D5 receptors from cell and tissue lysates. It also detects D5 in cultured cells and tissue sections by immunohistochemistry.
| Alternative Names | D5, DRD1B, Dopamine Receptor 5, D(1B)Dopamine Receptor |
| IUPHAR Target ID | 218 |
| UniProt ID | P21918 |
| Western Blot (WB) | 1:1000 |
| Immunohistochemistry (IHC) | 1:100 |
| Species Reactivity | Human, Mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Immunogen | A synthetic peptide presents carboxyl-terminal tail of human D5. |
| Form | Liquid |
| Purification | Antigen affinity chromatography |
| Storage buffer | Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide |
| Storage conditions | short-term 4°C, long-term -20°C |
Figure 1. Validation of the Dopamine Receptor 5 in transfected HEK293 cells. Native HEK293 cells (MOCK) or HEK293 cells stably expressing the dopamine receptor 5 (D5) were lysed and immunoblotted with the phosphorylation-independent anti-D5 antibody (7TM0218N) at a dilution of 1:1000.
Figure 2. Immunohistochemical identification of Dopamine Receptor 5 in mouse hippocampus. Sections were dewaxed, microwaved in citric acid, and incubated with anti-D5 (Dopamine Receptor 5) antibody (7TM0218N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.
Figure 3. Immunohistochemical identification of Dopamine Receptor 5 in human cortex. Sections were dewaxed, microwaved in citric acid, and incubated with anti-D5 (Dopamine Receptor 5) antibody (7TM0218N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.



